Rhodes Pharmaceuticals L.P.
USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Rhodes ranks #25,089 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.
- #25,089
- of 49,997 US assignees by volume
- Top 35%
- by Innovation Score (40.6/100)
- 20.9
- avg claims per patent
- -17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R25089 · US Corporation #25,089 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #25,089/49,997
- PHOTO-FINISH Renew Medical
- CPC-NARROW A61K · 3 areas
- INNOV-PAR 40.6/100
- CLAIMS-DENSE 20.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Renew Medical Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Rhodes’s 40.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Rhodes
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Rhodes Pharmaceuticals · this assignee
Rhodes Pharmaceuticals · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Rhodes's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Rhodes?
Each dot is one of Rhodes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rhodes’s own 20.9 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Rhodes's grants concentrate
Rhodes Pharmaceuticals L.P. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2017. By volume, Rhodes sits between Renew Medical Inc. and RightEye, LLC.
Rhodes's three-year grant acceleration
Rhodes Pharmaceuticals L.P. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Rhodes's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Renew Medical
Renew Medical Inc.
11 patents
- Rentrak
Rentrak Corporation
11 patents
- Republic of Korea…
Republic of Korea (National Forensic Service Director Ministry of Public Administration and Security)
11 patents
- Revivicor
Revivicor, Inc.
11 patents
- Ribon Therapeutics
Ribon Therapeutics, Inc.
11 patents
- Ricoh Production…
Ricoh Production Print Solutions LLC
11 patents
- Ridgeline
Ridgeline, Inc.
11 patents
- Righteye
RightEye, LLC
11 patents
- Rhodes Pharmaceut… ◀
Rhodes Pharmaceuticals L.P.
11 patents
What this shows Rhodes holds 11 patents at rank #25,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rhodes
By rank, the assignees closest to #25,084 in granted patent volume.
- Renew Medical Inc. #25,080 · 11 patents
- Rentrak Corporation #25,081 · 11 patents
- Republic of Korea (National Forensic Service Director Ministry of Public Administration and Security) #25,082 · 11 patents
- Revivicor, Inc. #25,083 · 11 patents
- Ribon Therapeutics, Inc. #25,085 · 11 patents
- Ricoh Production Print Solutions LLC #25,086 · 11 patents
- Ridgeline, Inc. #25,087 · 11 patents
- RightEye, LLC #25,088 · 11 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Rhodes's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Rhodes's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2018 | 4 | 36.4% |
| 2019 | 1 | 9.1% |
| 2021 | 1 | 9.1% |
| 2023 | 3 | 27.3% |
| 2024 | 1 | 9.1% |
Which technologies does Rhodes Pharmaceuticals L.P. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Rhodes Pharmaceuticals L.P.'s patent record in context - here's where to go next.
- Rhodes Pharmaceuticals L.P.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #25,089 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Rhodes Pharmaceuticals L.P. against Renew Medical Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.